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It has been reported that HCV can infect not only hepatocytes but also various kinds of lymphoid cells. Although many reports
have described the biological signiﬁcance of lymphotropic HCV, the issue remains controversial since the target lymphoid cells
might have various kinds of functions in the immune system. One of the important roles of lymphoid cells in HCV replication is
being a reservoir of HCV. Several groups described the detection of HCV-RNA in lymphoid cells after HCV eradication in plasma.
Another important role of lymphotropic HCV is that it acts as a carcinogenic agent and induces immune dysfunction. In this
paper, we summarize the reports regarding the biological signiﬁcance of lymphotropic HCV in representative lymphoid cells.
1.Introduction
Hepatitis C virus (HCV) infects about 170 million people
worldwide causing chronic hepatitis, liver cirrhosis, hepa-
tocellular carcinoma, B-cell lymphoma, cryoglobulin-related
disease, and various kinds of autoimmune diseases [1–3].
HCV is basically a hepatotropic virus that causes liver dis-
ease. However, HCV replication is detected not only in
hepatocytes but also in B cells, T cells, monocytes, dendritic
cells (DCs), and peripheral blood mononuclear cells [4–13].
The existence of HCV strains with preferential lymphocyte
tropism suggests the potential role of B cells and T cells
as an HCV reservoir [14–17]. Moreover, the existence of
H C Vi nl y m p h o i dc e l l sc o u l dc o n t r i b u t et ov a r i o u sB - c e l l
proliferativedisordersincludingB-celllymphomaandmixed
cryoglobulinemia and dysregulation of the cellular and hu-
moral immune responses that have major roles in the
immunopathogenesis of HCV persistent infection [18–28].
HCV infects hepatocytes, lymphoid cells, and probably other
cells through CD81 and several receptor candidates. The
expression of CD81 could be detected in various types of
cells, including hepatocytes, B cells, T cells, and monocytes,
indicating that these types of cells are potential targets of
HCV infection [13]. Previously, Sung et al. reported that
HCV persistently produced from a particular B-cell line
(SB), which was established from an HCV-positive B-cell
lymphoma, can infect and replicate in established B-cell lines
(Raji, Daudi) and primary B lymphocytes [23]. Moreover,
we reported that two T-cell lines (Molt-4 and Jurkat) and
primary na¨ ıve T lymphocytes were infected with SB culture
supernatant [13, 27, 28]. Machida et al. reported that HCV
replicationinBlymphocytescouldcontributetothecarcino-
genesis of B cells based on this useful in vitro system [29, 30].
Not only Machida’s group but also many groups reported
the evidence of HCV replication in lymphoid cells [18, 31–
38]. Various studies about the biological signiﬁcance of HCV
infection in lymphoid cells have been reported, although
there were some negative reports regarding HCV replication
in lymphoid cells [39–41]. Therefore, understanding the
various eﬀects of lymphotropic HCV is needed to treat the
extrahepatic manifestations of HCV infection. In this paper,
we summarize the various studies showing evidence of HCV
replication and discuss the biological signiﬁcance of HCV
replication in lymphoid cellsaccording to the various subsets
of lymphoid cells.
2.Biological Signiﬁcanceof
HCVInfection inB Lymphocytes
Many reports indicating the existence of HCV in B lympho-
cytes and B-cell lymphoma have been published, and many2 International Journal of Microbiology
of these focused on the relevance of HCV infection to B-cell
proliferative diseases including B-cell lymphoma and cryo-
globulinemia [18, 23, 42, 43]. Evidence of HCV infection in
B lymphocytes could be detected using PCR-based methods.
The detection of negative-strand HCV-RNA was widely used
to prove the replication of HCV in the cells. However, the
amount of negative-strand HCV-RNA is usually quite low
in comparison to positive-strand HCV-RNA [28]. Therefore,
many groups including us used nested PCR with rtTh poly-
merase that could reduce the risk of false-positive detection
[13, 27, 28, 31, 44]. In addition to nested PCR for the
detection of negative-strand HCV-RNA, immunostaining of
HCV individual proteins was used to detect lymphocytes
with HCV replication [28, 45]. False positive and negative
ampliﬁcation of HCV RNA frequently occurred due to the
very little amount of HCV-RNA as compared with the large
excess of total cellular RNA, resulting in underestimation of
viral RNA copies. Underestimation of RNA copies and wide
standard deviation were observed in intracellular HCV RNA
quantiﬁcation by conventional real-time PCR, particularly
with very low amount of HCV-RNA (102 to 104 copies/ug)
[28]. On the other hand, the HCV-NS3 protein could be
detected over 50% of B cell line with lymphotropic HCV
infection [45]. Discrepancies of these data might be due to
the detection methods. Therefore, we need to consider the
character of detection methods and detection limit carefully.
Sung et al. established B-cell lymphoma cell lines persis-
tentlyinfectedwithhepatitisCvirusinvivoandinvitro[23].
The cell lines continuously produce infectious HCV virions
in culture. The virus particles produced from the culture
had a buoyant density of 1.13 to 1.15g/mL in sucrose and
could infect primary human peripheral blood mononuclear
cells (PBMCs) and an established B-cell line in vitro [23].
This lymphotropic HCV strain was useful to investigate the
biological signiﬁcance of HCV replication in lymphoid cells.
It has been reported that the replication of HCV in
B lymphocytes could induce error-prone DNA polymerase
zeta,polymeraseiota,andactivation-inducedcytidinedeam-
inase (AID), which contribute to enhancing the mutation
frequency [30]. Moreover, the cellular DNA damage and
mutation were mediated by nitric oxide (NO) and reactive
oxygen species (ROS) [20, 29]. However, not only HCV
replication in B lymphocytes but also the direct HCV-
E2 CD81 interaction could induce hypermutation of the
immunoglobulin gene in B cells. E2-CD81 interaction on B
cellstriggeredtheenhancedexpressionofAID[46].Recently,
another group reported that persistent expression of the full
genome of HCV in B cells induces the spontaneous devel-
opment of B-cell lymphoma in vivo [47]. They established
HCV transgenic mice that express the full HCV genome in
B cells and observed a 25% incidence of diﬀuse, large B-cell
non-Hodgkin lymphomas. Moreover, it has been reported
that HCV replication could enhance the RIG-I expression
mediated by interferon regulatory factor-2 (IRF-2) in human
peripheral blood B lymphocytes. These reports explained
the mechanism of carcinogenesis in lymphocytes. However,
the relation between lymphotropic HCV and mixed cryo-
globulinemia, one of the lymphoproliferative diseases, has
been analyzed by many groups [3, 48–50]. Sansonno et al.
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Figure 1: A schema of the biological signiﬁcance of HCV replica-
tion in B cells is shown. The representative eﬀects of lymphotropic
HCV on B cells are shown in this ﬁgure.
reported that HCV replication could be detected especially
in chronic HCV with mixed cryoglobulinemia [50]. The
mechanisms of the induction of mixed cryoglobulinemia by
lymphotropic HCV replication have not been clariﬁed yet
exceptfortheinductionofhypermutationofIg-relatedgenes
and the stimulation of lymphocyte [45] (Figure 1).
It has been reported that the B lymphocyte reservoir of
HCV is one of the important issues regarding the biological
signiﬁcance of lymphotropic HCV [17]. Recently, it was
found that CD27+ memory B cells were more resistant to
apoptosis than CD27− B cells. CD27+ memory B cells might
be an HCV reservoir for persistent infection in chronic hep-
atitis C patients [51]. Moreover, a possible mechanism by
which the innate immune system is blocked in B cells,
which is necessary for HCV to infect B cells persistently, was
reported [14] (Figure 1). TANK-binding kinase-1 (TBK1)
and IκB kinase ε (IKKε) are essential for IRF-3 phosphor-
ylation, and both kinases were markedly enhanced in B cells
with hepatitis C infection. However, the reduced expression
of heat shock protein of 90kDa, a TBK1 stabilizer, and the
enhanced expression of SIKE, an IKKε suppressor, were
observed in B cells, and these might suppress the kinase
activity of TBK1/IKKε for IRF-3 phosphorylation in CHC
patients [14].
3.Biological Signiﬁcanceof
HCVInfection inT Lymphocytes
Various groups reported that HCV could be detected not
only in B lymphocytes but also in T lymphocytes, whichInternational Journal of Microbiology 3
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Figure 2: The schema of the biological signiﬁcance of HCV repli-
cationinTcellsisshown.Therepresentativeeﬀectsoflymphotropic
HCV on T cells are shown in this ﬁgure.
could contribute to the humoral and cellular immune re-
sponses [8, 31]. Many research groups established HCV
replication systems using T-cell lymphoma cell lines more
than a decade ago [4, 5, 10, 11, 32]. One group reported that
human T-lymphotropic virus type I infected cell line MT-
2 was susceptible to HCV infection [4, 5]. Not only HTLV-I
butalsoEpstein-Barr(EB)virusenhancedtheabilityofHCV
to replicate in T-cell lines [35]. These reports suggested that
the existence of other viruses might change the sensitivity of
HCV infection in T lymphocytes. It is important to analyze
the possibility that the susceptibility of HCV can be changed
byotherviruses,sinceHCV/HIV coinfectionis animportant
issue [52, 53]. However, the biological signiﬁcance of HCV
replication in T lymphocytes has not been clariﬁed yet.
We previously reported that lymphotropic HCV strain (SB-
HCV) could be replicated in two T-cell lines (Molt-4 and
Jurkat)andprimaryTlymphocytes,especiallyinna¨ ıveCD4+
T lymphocytes with proliferative stimulation [13, 27, 28].
The negative strand HCV-RNA that is the evidence of viral
replication could be detected temporarily after inoculation.
The amount of HCV-RNA detected in T lymphocytes was
lower than in B lymphocytes in this infection system. The
amounts of negative strand RNA and positive-strand RNA
in B cell lines were at least 4 times higher than those of T-
cell lines [28]. It has been reported that depletion of CD8+
cells could increase the positive rate of HCV-RNA in PBMC.
CD8+ T cells have a strong ability to produce the IFN-g
that could suppress the HCV replication [54]. In our study,
the negative-strand HCV-RNA could not be detected in
CD8+ T cells. We have reported that HCV replication could
aﬀect IFN-g/STAT-1/T-bet signaling by reducing the amount
of phospho-STAT-1 in Molt-4 and human primary na¨ ıve
Tl y m p h o c y t e s[ 13, 28]. Moreover, HCV-replication could
inhibit proliferation and enhance Fas-mediated apoptosis by
downregulating the expression of CD44 splicing variant 6
[27] (Figure 2). In addition to lymphotropic SB-HCV strain,
it has been reported that the wild-type HCV could infect
human T lymphocytes with T-cell-stimulating mitogens
[34]. Another group reported that HCV core protein
upregulated anergy-related genes using a Jurkat T cell line
stably expressing HCV core protein [26]. This cell line
showed increased activation of NFAT transcription factor
and impaired IL2 promoter activity [24] (Figure 2). The
expression of HCV core in T lymphocytes might contribute
totheestablishmentofpersistentinfectionsbyinducingCa2+
oscillations that regulate both the eﬃcacy and information
content of Ca2+ signals and are ultimately responsible for the
induction of gene expression and functional diﬀerentiation
[25]. Coinfection with HCV and HIV is associated with
increased HCV replication and a more rapid progression to
severe liver disease, including the development of cirrhosis
and hepatocellular carcinoma. One group reported that
HCV, HIV-1, and human herpes virus 6 were coinfected in
single T cells. Coinfection of a T cell by all three viruses was
conﬁrmed by transmission electron microscopy [55].
4.Biological Signiﬁcanceof
HCVInfection inMonocyteandDCs
It has been reported that HCV could infect not only B and
T lymphocytes, but also monocytes and DCs [56]. Recently,
a group reported that HCV could infect CD14+CD16+ cells
but not CD14+CD16− cells. They found that one of the
important HCV receptors, CD81, is highly expressed on
CD14+CD16+ cells but not on CD14+CD16− cells [57]
(Figure 3). A group reported that negative strand HCV-RNA
was most commonly present in monocyte/macrophages
followed by T cells and B cells in 10 HCV/HIV coinfected
patients [58]. Although the samples size of this study was
not so large, we need to consider the signiﬁcance of HCV
replicationinmonocytes,especiallyinHCV/HIVco-infected
patients. The interaction between monocytes and B and T
lymphocytes might have an important role in the immuno-
pathogenesis of HCV infection. In addition to the eﬀects on
cellfunction,theexistenceofHCVinmonocytesmightserve
as an HCV reservoir as seen in B and T lymphocytes [15].
Dendritic cells (DCs), which play a central role in coor-
dinating the immune response in HCV infection, have been
studied by many research groups. DCs are the most potent
activators of CD4 T cells for supporting Th1 diﬀerentiation,
which is important for the cellular immune response. It has
been reported that DCs from chronic hepatitis C patients
expressed lower amounts of CD86 and IL12 than those from
healthy subjects [59]. Moreover, other groups have reported
that the existence of HCV in DCs might suppress the
allostimulatory function, although the detailed mechanism4 International Journal of Microbiology
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Figure 3: The schema of the biological signiﬁcance of HCV
replication in DCs and monocytes is shown. The representative
eﬀects of lymphotropic HCV on DCs and monocytes are shown in
this ﬁgure.
of suppression was not clear [60–62] (Figure 3). In vitro
infection of human monocyte-derived DCs was carried out,
and strand-speciﬁc rTth reverse transcription polymerase
chain reaction was used to prove the HCV replication in
DCs [63]. Replicative-strand RNA could be detected in 3 of
24 peripheral DCs puriﬁcations. Moreover, the analysis of
the HCV quasispecies distribution in the peripheral DC
population of 1 patient showed the presence of a dominant
variant diﬀerent from that found in plasma with respect to
theprimaryaminoacidsequenceandphysiologicalproﬁleof
the hypervariable region 1 of glycoprotein E2 [64]. However,
the relationship between the dysfunction of DCs and HCV
replication has been still controversial [65].
5. HCVInfection in Nonparenchymal Liver
Cells and Other Lymphoid Cells
Nonparenchymal liver cells include lymphocytes, kupﬀer,
polymorphonuclear, pit, endothelial, stellate and ﬁbroblast-
like cells.One of the curious subsets of nonparenchymal liver
cells is hepatic stellate cells (HSCs) that play an important
role in the control of extracellular matrix synthesis and
degradation in ﬁbrotic livers. One report described that
HCV-core antigen could colocalize with large lipid droplets
present in HSC and with collagen ﬁbers in the extracellular
matrix. These data indicated that HCV-core antigen in the
stellate cells might modulate the immune function and
ﬁbrosis [66]. However, the amount of HCV-RNA and the
level of HCV replication could not be mentioned in this
report. More recently, it has been reported that HCV-RNA
replication could aﬀect the gene expression of extracellular
matrix-related molecules in HSC [67]. In that report, they
used subgenomic HCV replicon. The average amount of
HCV RNA was 3.9 copies × 105/ug total RNA.
Pluripotent hematopoietic CD34+ cells were another cu-
rious target of HCV replication since these cells have the
ability to develop various kinds of cells. It has been reported
thatpositive-andnegative-strandHCV-RNAandHCVindi-
vidual proteins could be detected in CD34+ hematopoietic
progenitor cells [68]. The amount of negative-strand HCV-
RNA was 1 × 103 HCV-RNA Eq. Moreover, the existence of
HCVnotonlyinperipheralbloodmononuclearcellsbutalso
in bone marrow mononuclear cells has been reported [69].
These observations are important since transplantation of
allogenic CD34+-selected peripheral stem cells can result in
the transmission of hepatitis C virus from an infected donor
[70].
6. Concluding Remarks
Although various reports described the biological signiﬁ-
cance of HCV replication in lymphoid cells, these reports
were not conclusive due to the lack of eﬃcient in vitro
culture systems. However, we should not underestimate the
eﬀect of HCV replication in lymphoid cells. In this paper,
we focused on the eﬀect of HCV replication in lymphoid
cells. In addition to the role as an HCV reservoir, various
reports described that HCV replication in lymphoid cells
could induce dysregulation of the immune system. We need
to focus not only on suppression of the immune system
but also on stimulation of the immune system, since the
prevalence of autoimmune diseases is much higher than in
healthy subjects. A study regarding the relationship between
lymphotropic HCV and autoimmune diseases is ongoing in
our laboratory. As for the understanding of autoimmune
diseases, HCV persistent infection might be one of the rep-
resentative models of viral-induced autoimmune diseases.
Recently, the technologies of deep sequencing, immunoas-
says with increased numbers of multicolor ﬂow cytometry
analyses, and chimera mice with human lymphocytes have
been developed. These technologies, together with previous
data, might be able to clarify the biological signiﬁcance of
lymphotropic HCV.
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